$33 million joint funding fight against cervical cancer to benefit Zambia

 $33 million joint funding fight against cervical cancer to benefit Zambia

 

Zambia is one of the six countries to benefit from the 33 million US dollars joint funding from Unitaid and Clinton Health Access Initiative project fight against cervical cancer.

Unitaid and Clinton Health Access Initiative have since signed an innovative grant that will bring artificial intelligence and affordable treatment and screening to the fight against cervical cancer that kills one woman every two minutes and disproportionately affects low-resource countries and women living with HIV.

The 30 months long project slated to start in July this year, will be implemented in India, Kenya, Malawi, Nigeria, Rwanda, South Africa and Zambia.

With the aim of achieving 1 US dollar screen-and-treat solutions, the project will deploy improved screening tools, introduce new portable devices for treatment and advance easy-to-use artificial intelligence-based tools for screening of precancerous lesions, according to Stanslous Ngosa.

The Ministry of Health Head Media Relations said precancerous lesions can progress to life-threatening cervical cancer if left untreated.

He said the Cervical cancer is the fourth most common cancer in women and it affects over half a million women each year and kills more than a quarter of a million.

Mr Ngosa said virtually all cervical cancers are caused by infection with human papillomavirus, a very common sexually-transmitted infection.

He said in high-income countries, several strategies have proved successful in decreasing the cervical cancer burden, including early detection and treatment of precancerous lesions while in remote settings, progress has been held back by high costs, ineffective screening methods and ill-adapted treatment devices.

Alice Nachilembe

https://tiozambia.com

Alice Nachilembe is a Journalist who yearns for a better country with leaders being accountable to their mandate without oppressing the governed.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.